Abstract Mucosal lymphocyte homeostasis involves the dynamic interaction of enteric microbiota, the intestinal host epithelium, and the mucosal immune system. Dysregulation of mucosal lymphocyte homeostasis results in a variety of intestinal disorders, notably inflammatory bowel diseases like ulcerative colitis and Crohn's disease. One key cellular component regulating homeostasis are B lymphocytes that reside in gut-associated lymphoid tissue. This compartment includes Peyer's patches, isolated lymphoid follicles, lamina propria, and mesenteric lymph nodes. Recent data have pointed to two new and exciting aspects of B cells in the gut. First, there has been progress on identification and functional analysis of abundant isolated lymphoid follicle B cells that are key mediators of IgA genesis. Second, several groups have now clarified the functional identification and characterization of immunoregulatory B cells in the gut. This review examines the novel aspects of these B cells, and examines how each plays a role in mediating mucosal homeostasis in this bacteria-laden compartment.
Introduction
The gut mucosa is the immunologic center of the body, harboring 80% of the body's leukocyte population. These leukocytes are absolutely required for host homeostasis with an estimated 100 trillion bacteria that reside in the intestine. Dysregulation of homeostasis results in a class of diseases collectively termed inflammatory bowel disease.
The intestinal mucosa is comprised of several highly specialized cellular and anatomic components, each of which is required to maintain homeostasis. First, only a single epithelial cell layer separates enteric flora and environmental antigen from the sterile host. This cell layer actively contributes to barrier modes of defense via mucus production [1] , anti-microbial peptides (notably the Paneth cell subpopulation; [2, 3, 4] , and microbial sensing functions, which permit the epithelium to modify its production of barrier products, and recruit leukocytes [5, 6, 7] . Throughout the intestine, subepithelial lymphoid tissue is segmentally deployed beneath specialized, follicular-associated epithelium (FAE). FAE differentiation is induced by the underlying lymphoid cells, and is specialized for the traits permitting antigen sampling from the luminal environment for delivery to the subjacent lymphoid compartment [8, 9, 10] . These lymphoid sites are comprised of either Peyer's patches (PP) or isolated lymphoid follicles (ILF), each of which is critical for maintenance of homeostasis. In a more diffuse distribution, the intestinal epithelial cell layer overlays a lamina propria (LP) compartment, particularly enriched for plasma cells, macrophages, and dendritic cells [11, 12] , and the developmentally significant cryptopatch structures [13, 14, 15] . Finally, mesenteric lymph nodes (MLN) provide a draining secondary lymphoid compartment for the intestinal environment. Together, these compartments comprise anatomic sites for organization and induction and effector phases of immunity, which are essential for fecundity and survival of the host (Fig. 1) .
The leukocytes of these compartments play a key role in maintaining homeostasis to the enteric flora and food antigens, as well as maintaining immunity to infectious agents. One key leukocyte in maintaining homeostasis and immunity is the B lymphocyte. The most intensely studied function of B cells in the mucosa is in the genesis of IgA-producing plasma cells and is reviewed elsewhere [12] . While B cells of the PP and LP have been intensely studied, two unique populations of B cells have only recently been appreciated: ILF, and immunoregulatory B lymphocytes that reside in the MLN. These B cell subpopulations, which are components of the innate-like population of surveillance B cells [16, 17, 18] , are the subject of this review.
To properly form these B cell compartments, several steps must take place. First, B cells must develop and successfully mature at progenitor sites. The requirements for these initial phases of marrow B lymphopoiesis, and the possibility of serosal or mucosal B cell precursor populations, has been the subject of many excellent reviews, and will not be discussed here [19, 20, 21, 22, 23] . Second, once in the periphery, ILF and PP B cell precursors must successfully migrate into the gut mucosa and localize into their follicular sites. In the case of the PP, successful clones undergo antigen-dependent activation at that site, and proceed from there to the MLN, and finally to the LP, where they take up residence as plasma cells [12] . This sequential process has not yet been delineated for ILF B cells. However, there has been substantial progress on the shared and divergent genetic and molecular factors for development of these two subjacent B cell compartments.
ILF B cells
ILF B cells are a unique compartment of B lymphocytes that are found at the host bacterial interface of the bacteria-laden intestine. This unique structure has only recently been discovered, but significant strides have been made to yield a moderate understanding of how ILF B cells develop and mediate homeostasis. The focus of this section is to review what is currently known about ILF B cells.
ILF B cells were first carefully studied in a comparative fashion in humans [24] . Using the mouse as a model system because of its ready availability and potential genetic and biochemical manipulation, Hamada et al. [25] were the first to identify ILF in the intestine of these animals. ILF were identified in mice as small follicles (~0.1 mm), numbering 100-200 sites dispersed along the anti-mesenteric aspect of the small intestine. ILF are comprised primarily of B220 + CD19 + CD23 + IgM lo IgD hi CD5 Mac-1 cells. A small but significant IgA + B cell population is also present, and ILF typically display germinal center morphology, both reflecting antigenic stimulation and differentiation of ILF B cells. The cellularity of this compartment is substantial, and is equivalent or larger than the PP compartment (Velazquez et al., submitted).
Curiously, unlike PP and lymph nodes, ILF contain only minimal numbers of T cells, dendritic cells, and macrophages. Thus, the local factors that would normally facilitate Tdependent B cell activation are uncertain. Indeed, genetic and environmental parameters suggest a novel mode of B cell activation at this site (see below).
Structure
Several groups have reported on the structure of ILF, and it is depicted in Fig. 1 . ILF are predominated by B cells that are organized into a central follicle that may contain a germinal center [24, 25, 26] . These organized B cell structures clearly underlie a follicule-associated epithelium resembling M cells [25, 26] . M cells are known to play a major role in antigen uptake and transport from the lumen to the organized lymphoid structures, such as in the PP. Additionally, ILF are vascularized with vessels containing high endothelial venules, which suggests that the source of at least some of the leukocytes of the ILF are derived from cells migrating in from blood. Dendritic cells are also found interdispersed in ILF like in PP [25, 27] . Interestingly, some groups have reported that ILF lack the interfollicular T cell regions that are typically found in PP, while some B cell clusters contain interdispersed T cells [25, 26] . This likely represents different stages of antigenic respons-es of ILF. Together, the findings indicate that ILF are actively involved as a lymphoid organizing center, whose state of responsiveness is dynamically regulated. + [24] . Details of reported phenotypes of murine ILF T and B cell phenotypes are shown in Table 1 
Distribution
Interestingly, the distribution of ILF is similar in both humans and mice, pointing to the conserved importance of such a structure during the course of evolution. In humans, ILF are found throughout the small intestine, but are most abundant in ileum. Quantitative analysis shows that jejunal ILF are nine times more abundant in ileal ILF [24] . Similarly, in the mouse, ILF are most abundantly found in the distal small intestine and cecum ( [26] , and Velµzquez et al. submitted). Since enteric bacteria are most abundant in the distal small intestine and in the large bowel, the physical distribution of ILF points to the idea that they are induced at least in part by enteric microbial antigen stimulation. However, ILF (or PP) formation of the small intestine is largely independent of commensal bacteria [25, 26, 28] . B cell antigen recognition also does not appear to be required, since good cellularity of PP [28] or ILF (Velµz-quez et al. submitted) compartments occurs in LMPa and MD4 (HEL-specific Ig) transgenic mice. However, germinal center formation and numerical expansion occurs with bacterial stimulation [26, 28] . Analysis of these transgenic mice on the RAG2 / mice background suggest that T cell-dependent bacterial sensing is the key component of the germinal center response [28] , an idea also reflected in the failure of germfree mice to support formation of B cell-activating invariant MR-1-restricted T cells [29] .
Antibody formation ILF B cells are reactive for the germinal center markers GR-7 and PNA [25, 26, 27] . Also, BrdU incorporation into the blasting germinal center ILF is approximately equal to that in PP, indicating the importance of ILF B cells in antibody maturation in the intestine.
Activation-induced cytidine deaminase (AID) is required for the Ig class switch recombination and somatic hypermutation. Deficiency of AID provided an important insight into the role of ILF B cells in mediating homeostasis in the intestine. AID deficiency resulted in B cell hyperplasia in the ILF [27] . It is hypothesized that because B cells are unable to mature into antibody-producing cells, they assume a hyperactivated state. Most striking was an altered distribution of enteric flora, including a 100-fold increase in the number of anaerobic bacteria in AID-deficient animals. Antibiotic treatment resulted in abrogation of the ILF B cell hypertrophy [27] . Lastly, in hypertrophic ILF there was a limited, oligoclonal, B cell receptor specificity [27] . These findings highlight the role of mucosal B cell response in control of the commensal bacterial population, in some degree due to B cell receptor (BCR)-mediated antigenic stimulus. Indeed, clonal expansion of antigen-specific B cells can be guided by antigenic specificity towards commensal bacteria [30, 31] .
Another critical piece of data that highlights the function of ILF B cells examined class switch recombination from IgM to IgA in ILF B cells. A close examination of inductive sites including MLN, PP and ILF demonstrated that only inductive sites contained IgM + B cells, while effector sites such as the LP contained only IgA + plasmablasts [32] . Upon examination of markers of recent recombination, only inductive sites such as ILF contained markers such as aCT (circular segments of DNA that are looped out as a result of class switching from IgM to IgA), Im-Ca mRNA (germline DNA that recombines as a result of looping out of aCT) during class switch recombination, and AID [32] .
Antigen recognition
To understand factors that drive the development of ILF B cells, both BCR and non-BCR requirements must be examined. It is well known that T cells provide critical factors, such as CD40, required for B cell maturation to antibody-producing plasma cells. Secretory IgA is most critical for maintaining homeostasis in the bacteria-laden intestine. Therefore, as one would predict, ILF B cells are deficient in genetically deficient TCRb animals [25] . Athymic nude mice deficient in T cells are also deficient in germinal center ILF B cells. Also, ILF B cells are deficient in RAG-and muMT-deficient animals as recombination and IgM-BCR expression is required for development, respectively (Table 2) [25] .
A series of genetically altered mice have been studied for ILF formation with selective deficiencies in PP, T cells, cryptopatches (known to contain local T cell precursors), or a combination of these deficiencies. This analysis showed that ILF are unique from both PP and cryptopatches in histogenesis and lymphocyte composition [25] . The Newberry group has further segregated ILF based on level of maturity and pointed to a critical requirement for ILF. ILF require lymphotoxin (LT) b-receptor from the stromal cell compartment and LT-sufficient B cells (Table 2) . Unlike PP and MLN this interaction is not required during gestation. Therefore, ILF formation can be induced de novo in adult with LTb receptor (LTbR), a striking and unique feature of ILF B cells [26] .
A well-characterized and critical function of B cells in the intestine is the production of IgA. The paradigm is that B cells of the intestine differentiate to produce abundant amounts of IgA that can be transported across the epithelium [12] . IgA in the lumen of the GI can then bind to and inhibit potentially deleterious bacterial flora. However, the importance of signals mediated by BCR for the presence of ILF in the intestine is not clear. Studies have demonstrated the importance of the BCR signal strength in ILF B cell homeostasis, and defined two key molecular mediators (Velµzquez et al. submitted). Deficiency in BCR signaling pathway mediated by Btk (the xid mutation in CBA/N mice) re- (Table 2) . Therefore, the proper tonic biochemical signal must be delivered to drive ILF B cell homeostasis, while antigen specificity is not an absolute requirement (Velµzquez et al. submitted).
Immunoregulatory B cells
A surprising finding in recent years has been the immunoregulatory role of B cells in immune responses, observed in models of respiratory inflammation, multiple sclerosis, and inflammatory bowel disease [37, 38, 39, 40] . In this regard, the detailed study of B cells in the gut may provide new insights into mucosal homeostasis. Several groups have reported the immunoregulatory role of B cells. Tsitoura et al. [37] have demonstrated that antigenspecific B cells are highly effective in inducing tolerance to respiratory antigen. In the mouse model of multiple sclerosis, EAE, it has been demonstrated that B cells play a role in immune modulation in the acute disease process [38] . Similarly, mice deficient in B cells have a defect in the induction of oral tolerance [39] . Work completed by Bhan, Mizoguchi and their colleagues [40] has also demonstrated that a CD1-positive B cell subset induced in the gut under inflammatory conditions performs an immunoregulatory function via effects mediated by IL-10 production. Studies in our lab also demonstrate a critical role of B cells in immune regulation of T cells from colitic mice (Wei et al., submitted). Each study examining immunoregulatory B cells of gut was unique because these studies examined multiple models of chronic intestinal inflammation, including TCRa / [40] as well as the transfer models of Gai2 / and CD45RB hi (Wei et al., submitted). Therefore, B cell protection from colitis is not an artifact of an experimental system. Importantly, CD1d is required to induce IL-10 production in B cells in the TCRa / model of colitis. IL-10 produced by CD1d hi B cells down-modulates inflammation mediated by IL-1 and STAT3 [40] . In both Gai2 / and CDRB45 hi transfer models of colitis, B cells from MLN of wild-type mice can protect from colitic T cells (Wei et al. submitted). Protection is associated with expansion of NKT cells in the MLN and CD4 + CD8 + T cells in the gut. B cells in these model systems home preferentially to MLN, and are not detected in the intestine (ILF, PP, or LP). An interesting genetic requirement for the formation of these cells is Gai2, since null mice lack B cells with this immunoregulatory activity. Since this null mutation results in a selective deficiency of surveillance B cells, the finding suggests that cells with this immunoregulatory activity are included within the surveillance B cell subsets. However, the location of immunoregulatory B cell development, and the nature of their antigen specificity, remains to be defined.
Conclusion: ILF and immunoregulatory B cells in mucosal homeostasis
In the gut mucosa, there are three major lymphoid organizing centers, two of which have been intensely studied, PP and MLN. The third lymphoid organizing center, ILF, have only recently been carefully studied. ILF B cells, like those of PP, reside at the host/bacte-ria interface and are capable of responding to antigenic challenges. What can we conclude or speculate regarding the role of ILF B cells in mucosal homeostasis?
One major function of ILF B cells is as an organizing center for IgM + B cell maturation into IgA-producing plasmablasts. Since ILF cells reside at the host bacteria interface, they provide a first line of antibody responsiveness and protection of the host from both enteric and infectious organisms. A key characteristic of ILF that differentiates it from PP and MLN is that they are inducible after birth by LTbR. Therefore, ILF are dynamically regulated. We hypothesize that ILF respond to enteric flora or infectious pathogens that are able to surpass innate lines of defense, such as mucosa, defensins or galectins. Upon induction, ILF drive the maturation of IgA-producing cells. The resulting antibody can then bind to and inhibit potentially harmful flora. Based on distribution and abundance, ILF B cells are at least as abundant as PP B cells. Therefore, while PP and MLN are also capable of driving B cell differentiation into IgA plasmablasts, ILF, in a normal individual, may represent the major source of IgA genesis. This fact becomes particularly important when mechanical and innate barriers are compromised by flora and infectious agents.
In this regard, failure of the appropriate maturation and responsiveness of ILF B cells may lead to dysregulation of homeostasis. Failure of ILF formation may result in an insufficient antibody responsiveness that allows for opportunistic pathogens or enteric flora to establish successful infection. After some time, PP and MLN may be capable of compensating for IgA genesis, while a robust CD4 T cell response here would also contribute to preventing disease progression.
An interesting facet of ILF formation is that there is not an absolute requirement of antigen specificity. This suggests that other, perhaps innate, sensing systems are responsible for the formation of ILF B cells. Supporting this hypothesis is the unique absolute requirement of LT/LTbR interaction for ILF B cell formation. An exciting possibility is the evolutionary selection of germline VDJ segments that preferentially recognize enteric and pathogen-associated molecular patterns, EAMP and PAMP, respectively. In such an event, EAMP and PAMP engagement would be sufficient to drive a protective antibody response from multiple flora without specific antigenic engagement, a favorable evolutionary characteristic.
B cells of the MLN form a new and exciting component of mucosal homeostasis. Immunoregulatory B cells of the MLN can act in two unique aspects of homeostasis. They can be induced either during a chronic inflammatory condition or can act to prevent colitis onset. Importantly, CD1d is required to mediate immunoregulation. Therefore, we hypothesize that immunoregulatory B cells act on NK cells in the MLN. This interaction can drive the selective outgrowth of regulatory CD4 + CD8
+ T cells that act as the regulatory cell at the effector site. It appears that IL-10 is important for this immunoregulation. However, it is not clear what the role of NKT or CD4 + CD8 + T cells is in IL-10 production. In addition, it is not clear how other immunoregulatory cytokines, such as TGF-b, or other immunoregulatory CD4 T cells also inhibit inflammation in these model systems. It is possible that these other cytokines and T regulatory cells represent an additional, redundant, level of regulation to prevent a chronic or hyper-responsiveness in the gut.
In conclusion, recent studies on ILF and immunoregulatory B cells of the gut highlight the importance of B cell subsets in mediating homeostasis in intestine. Further studies examining the molecular mechanisms of homing, retention and activation of these cellular subsets in the mucosa will help us to further understand how to therapeutically modulate the presence and activity of these cell subsets. Such modulation may include activity of immune regulation during chronic inflammation, such as in inflammatory bowel disease, or to drive an immune response to an infectious disease in an otherwise nonresponsive host, such as an infant or immunocompromised individual.
